These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34093576)

  • 1. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
    Bailén R; Vicario JL; Solán L; Sánchez-Vadillo I; Herrera P; Calbacho M; Alenda R; López-Lorenzo JL; Humala K; Chinea A; Sánchez-Pina J; Balas A; Moreno MÁ; Arzuaga J; Pradillo V; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M
    Front Immunol; 2021; 12():674658. PubMed ID: 34093576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
    Bailén R; Alenda R; Herruzo-Delgado B; Acosta-Fleitas C; Vallés A; Esquirol A; Fonseca M; Solán L; Sánchez-Vadillo I; Bautista G; Bento L; López-Godino O; Pérez-Martínez A; Torrent A; Zanabili J; Calbacho M; Moreno MÁ; Pascual-Cascón MJ; Guerra-Domínguez L; Chinea A; García-Cadenas I; López-Corral L; Boix-Giner F; López Lorenzo JL; Humala K; Duarte R; Sampol A; Heras I; Vicario JL; Balas A; Oarbeascoa G; Fernández-Caldas P; Anguita J; Kwon M
    Front Immunol; 2023; 14():1165759. PubMed ID: 37304258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
    Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
    J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders.
    Lima ACM; Bonfim C; Getz J; do Amaral GB; Petterle RR; Loth G; Nabhan SK; de Marco R; Gerbase-DeLima M; Pereira NF; Pasquini R
    Transplant Cell Ther; 2022 Oct; 28(10):698.e1-698.e11. PubMed ID: 35882362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.
    La Rocca U; Perrone MP; Piciocchi A; Barberi W; Gesuiti P; Laurenti L; Cinti P; Gozzer M; Bafti MS; Carmini D; Cinelli N; Cavallari C; Giovannetti G; Ricci R; Girelli G; Foà R; Martelli M; Coluzzi S; Iori AP
    Blood Transfus; 2024 Mar; 22(2):157-165. PubMed ID: 37847211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.
    Chang YJ; Zhao XY; Xu LP; Zhang XH; Wang Y; Han W; Chen H; Wang FR; Mo XD; Zhang YY; Huo MR; Zhao XS; Y K; Liu KY; Huang XJ
    J Hematol Oncol; 2015 Jul; 8():84. PubMed ID: 26156584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant.
    Zhu J; Wang Q; Liu Y; Dong Y; Liang Z; Yin Y; Liu W; Xu W; Sun Y; Wang B; Wang Q; Wang Q; Han N; Ren H; Li Y
    Int Immunopharmacol; 2023 Jul; 120():110299. PubMed ID: 37201405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
    Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R
    Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
    Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
    Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful haploidentical transplantation using plasma exchange and post-transplantation cyclophosphamide for severe aplastic anemia patients with anti-human leukocyte antigen donor-specific antibodies.
    Cao J; Pei R; Zhang P; Liu X; Chen D; Du X; Chen L; Wang T; Ye P; Lu Y
    Ann Hematol; 2021 Sep; 100(9):2381-2385. PubMed ID: 34230984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of immunosuppression intensified conditioning regimen for patients with strong positive pre-transplantation donor-specific anti-HLA antibodies (DSAs) undergoing haploidentical hematopoietic stem cell transplantation].
    Liu HX; Wei DL; Shao S; Jiang Y; Li S; Zhu J; Wang C; Zhao CX
    Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):654-659. PubMed ID: 37803839
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of allosensitized patients receiving allogeneic transplantation.
    Ciurea SO; Al Malki MM; Kongtim P; Zou J; Aung FM; Rondon G; Chen J; Taniguchi M; Otoukesh S; Nademanee A; Forman SJ; Champlin R; Gendzekhadze K; Cao K
    Blood Adv; 2021 Oct; 5(20):4031-4043. PubMed ID: 34474478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders.
    Lima ACM; Bonfim C; Getz J; Dornelles LN; do Amaral GB; Petterle RR; Loth G; Nabhan SK; Pereira NF; Pasquini R
    HLA; 2021 Jun; 97(6):493-504. PubMed ID: 33886161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
    Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462
    [No Abstract]   [Full Text] [Related]  

  • 16. Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes.
    Bramanti S; Calafiore V; Longhi E; Mariotti J; Crespiatico L; Sarina B; De Philippis C; Nocco A; Santoro A; Castagna L
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1395-1406. PubMed ID: 30826463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Xie Y; Parekh J; Tang Z; Wu D; Wu X
    Transplant Cell Ther; 2021 Aug; 27(8):687.e1-687.e7. PubMed ID: 33989833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple predictor for donor-specific anti-HLA antibody desensitisation in haploidentical haematopoietic stem cell transplantation.
    Li JM; Zhang ZL; Zhao JL; Wang YQ; Gong SS; Lei H; Wang XF; Hu XX; Cai XH
    HLA; 2024 Aug; 104(2):e15625. PubMed ID: 39091273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation.
    Jaime-Pérez JC; Cruz MLR; Mendoza-Ibarra SI; Moncada-Saucedo NK; Gómez-Almaguer D
    Rev Invest Clin; 2023; 75(5):249-258. PubMed ID: 37918011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients who underwent treatment for anti-HLA donor-specific antibodies before receiving a haploidentical hematopoietic cell transplant.
    Lipsitt A; Arnold P; Chi L; Carruthers K; Folk S; Fossey S; Keerthi D; Mamcarz E; Srinivasan A; Sharma A
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29993. PubMed ID: 36129238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.